- Home
- SLAB vs PCVX Comparison
SLAB vs PCVX Comparison
Compare SLAB & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLAB
- PCVX
- Stock Information
- Founded
- SLAB 1996
- PCVX 2013
- Country
- SLAB United States
- PCVX United States
- Employees
- SLAB N/A
- PCVX N/A
- Industry
- SLAB Semiconductors
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- SLAB Technology
- PCVX Health Care
- Exchange
- SLAB Nasdaq
- PCVX Nasdaq
- Market Cap
- SLAB 4.7B
- PCVX 4.0B
- IPO Year
- SLAB 2000
- PCVX 2020
- Fundamental
- Price
- SLAB $136.54
- PCVX $42.47
- Analyst Decision
- SLAB Buy
- PCVX Strong Buy
- Analyst Count
- SLAB 11
- PCVX 8
- Target Price
- SLAB $144.00
- PCVX $114.17
- AVG Volume (30 Days)
- SLAB 240.6K
- PCVX 2.0M
- Earning Date
- SLAB 11-04-2025
- PCVX 11-04-2025
- Dividend Yield
- SLAB N/A
- PCVX N/A
- EPS Growth
- SLAB N/A
- PCVX N/A
- EPS
- SLAB N/A
- PCVX N/A
- Revenue
- SLAB $703,203,000.00
- PCVX N/A
- Revenue This Year
- SLAB $37.61
- PCVX N/A
- Revenue Next Year
- SLAB $19.17
- PCVX N/A
- P/E Ratio
- SLAB N/A
- PCVX N/A
- Revenue Growth
- SLAB 29.66
- PCVX N/A
- 52 Week Low
- SLAB $82.82
- PCVX $27.66
- 52 Week High
- SLAB $160.00
- PCVX $118.54
- Technical
- Relative Strength Index (RSI)
- SLAB 54.35
- PCVX 64.05
- Support Level
- SLAB $125.14
- PCVX $42.75
- Resistance Level
- SLAB $138.94
- PCVX $45.12
- Average True Range (ATR)
- SLAB 4.55
- PCVX 2.14
- MACD
- SLAB 0.65
- PCVX 0.22
- Stochastic Oscillator
- SLAB 85.36
- PCVX 74.41
About SLAB Silicon Laboratories Inc.
Silicon Laboratories Inc Inc is a provider of secure, intelligent wireless technology for a more connected world. The company's integrated hardware and software platform, intuitive development tools, industry ecosystem, and robust support help customers build industrial, commercial, home, and life applications. Company make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with solutions that transform industries, grow economies, and improve lives. Company operates in USA, China, Taiwan and Rest of World, with maximum revenue from rest of the world.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.